Home / Meetings and Events

ABOUT CASSS MEETINGS

CASSS meetings bring together industry, regulatory, and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS Symposia and Fora provide venues for biopharmaceutical professionals to: 

  • Connect with a relevant global network.
  • Gain tangible knowledge for career advancement.
  • Learn best practices from prominent contributors in the industry.

  • Image of dark blue background with text 'CMC Strategy Forum Europe' CMC Strategy Forum Europe
    October 21 to 23, 2024

    Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Europe.

  • Bright orange graphic with text 'CASSS Discussion Groups' The Netherlands Area Biotech Discussion Group
    October 24, 2024

    The NLab Discussion Group is the first CASSS Discussion Group located outside the US and enables the local area community to meet and share ideas and experiences.

  • Bright orange graphic with text 'CASSS Discussion Groups' DC Discussion Group
    October 30, 2024

    The DC Discussion Group allows you to network in-person with DC-area CASSS members.

  • Image of DNA helix with text 'CGTP Summit' CGTP Fall Virtual Summit
    November 19, 2024

    The NEW CGTP Fall Virtual Summit is a one-day virtual program that will include two sessions with speaker presentations and extended panel discussions.

  • Image with text 'CASSS Consultants' Network' Consultants' Network
    November 25, 2024

    The purpose of the CASSS Consultants' Network is to facilitate discussions among consultants.

  • Image with text 'cmc strategy forum japan advancing biopharmaceutical development' CMC Strategy Forum Japan
    December 9 to 10, 2024

    Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Japan and the Asia/Pacific Region.

  • Image with hexagons and text 'CMC Strategy Forum North America Advancing Biopharmaceutical Development' CMC Strategy Forum North America
    January 27, 2025

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • Image of purple background with text 'WCBP' WCBP
    January 28 to 30, 2025

    The WCBP Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.

  • Image with text 'bioassays scientific approaches and regulatory strategies' Bioassays
    April 7 to 9, 2025

    Bioassays presents an opportunity to interact with key industry thought leaders and discuss topics such as current perspectives, strategies, and technologies used for bioassays.

  • Image of DNA helix with text 'CGTP Summit' CGTP Summit
    June 9, 2025

    This one-day Summit is designed to discuss pertinent challenges in the cell and gene therapy field through speaker presentations with interactive, in-depth panel discussions.

  • Image of DNA helix with text 'Cell & Gene Therapy Products Manufacturing, Quality and Regulatory Considerations' Cell and Gene Therapy Products
    June 10 to 12, 2025

    The Symposium will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field.

  • CE in the Biotechnology & Pharmaceutical Industries CE Pharm
    September 7 to 10, 2025

    The Symposium provides a forum for the discussion of recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals.

  • Red orange background with hexagon molecules and text 'Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry' Mass Spectrometry
    September 23 to 26, 2025

    The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry.

Fast Facts

  • Annually, CASSS holds 15 scientific, multi-day Symposia, Fora, and Discussion Groups around the world.
  • Attendees represent 30 regulatory agencies and 440 biopharmaceutical companies.
  • Members reside in 46 countries throughout North America, Europe, Asia, Africa, and South America.

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry, partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct